Table 12.
Potential common pathogens which cause infection in xenotransplant recipients.
Origin | Pathogens | Risk | Recipient testing assays | |
---|---|---|---|---|
Donor | Virus | PERV | Unknown | QNAT, Ab-based tests* |
PCMV | Known (NHP) | NAT, Ab-based tests* | ||
PLHV | Unknown | QNAT | ||
HEV | Known (human) | NAT | ||
PCV | Unknown | NAT | ||
Recipient | Virus | CMV | Known | QNAT, histopathology |
VZV | NAT, DFA | |||
HSV | Clinical, NAT, culture, Tzanck smear, histopathology | |||
EBV | QNAT, histopathology | |||
BKV | QNAT, histopathology | |||
HPV | Histopathology, speculum examination, cervical pap test with NAT | |||
Fungus | Candida species | Culture, histopathology | ||
Aspergillus species | BAL galactomannan, BAL NAT, chest CT, culture | |||
Cryptococcus species | Lateral flow assay over latex agglutination assay, culture, imaging of lung and CNS | |||
Pneumocystis jiroveci | Chest radiograph, serum lactic dehydrogenase, serum (1 → 3) β-d-glucan assay, sputum examination, direct immunofluorescent staining, histopathology | |||
Parasite | Strongyloides stercoralis | Parasitological or molecular tests of stool, lower respiratory or affected body fluids/tissues samples |
Abbreviations: Ab: antibody, BAL: bronchoalveolar lavage, BKV: BK polyomavirus, CMV: Cytomegalovirus, CNS: central nervous system, CT: computed tomography, DFA: direct fluorescent-antibody, EBV: Epstein-Barr virus, HEV: hepatitis E virus, HPV: human papilloma virus, HSV: herpes simplex virus, NAT: nucleic acid testing, NHP: non-human primate, PCMV: porcine cytomegalovirus, PCV: porcine circovirus, PERV: porcine endogenous retrovirus, PLHV: porcine lymphotropic herpes virus, QNAT: quantitative nucleic acid testing, VZV: varicella-zoster virus, *Antibody-based tests include serology, ELIZA, and western blot.